Director
An image of Diana McKenzie, a member of the Board of Directors at Vertex Pharmaceuticals

Diana McKenzie

Director
Audit and Finance Committee, Member
Management Development and Compensation Committee, Member
An image of Diana McKenzie, a member of the Board of Directors at Vertex Pharmaceuticals

Ms. McKenzie joined our board in 2020. Ms. McKenzie was the Chief Information Officer of Workday, Inc., a cloud-based financial and human capital management software company, from February 2016 until April 2019. From 2004 through February 2016, she held roles of increasing responsibility at Amgen Inc., a biotechnology company, most recently serving as Senior Vice President and Chief Information Officer. Ms. McKenzie served for 17 years at Eli Lilly and Company, a pharmaceutical company, in various leadership roles, focused on drug development, reducing time to market and improving technology and security standards. She currently serves as a member on the board of directors of agilon health, inc., MetLife, Inc., and Paradox AI, and as a Special Advisor to Brighton Park Capital. Ms. McKenzie also served as a member on the board of directors of Change Healthcare, Inc., a publicly traded healthcare technology company from August 2019 until it was acquired by United Health Group in October 2022. Ms. McKenzie holds a Bachelor of Science degree in computer information systems from Purdue University and completed the Information Technology Management Program at University of California, Los Angeles, and the CERT Certification for Cybersecurity Oversight from Carnegie Mellon’s Software Engineering Institute.

Ms. McKenzie joined our board in 2020. Ms. McKenzie was the Chief Information Officer of Workday, Inc., a cloud-based financial and human capital management software company, from February 2016 until April 2019. From 2004 through February 2016, she held roles of increasing responsibility at Amgen Inc., a biotechnology company, most recently serving as Senior Vice President and Chief Information Officer. Ms. McKenzie served for 17 years at Eli Lilly and Company, a pharmaceutical company, in various leadership roles, focused on drug development, reducing time to market and improving technology and security standards. She currently serves as a member on the board of directors of agilon health, inc., MetLife, Inc., and Paradox AI, and as a Special Advisor to Brighton Park Capital. Ms. McKenzie also served as a member on the board of directors of Change Healthcare, Inc., a publicly traded healthcare technology company from August 2019 until it was acquired by United Health Group in October 2022. Ms. McKenzie holds a Bachelor of Science degree in computer information systems from Purdue University and completed the Information Technology Management Program at University of California, Los Angeles, and the CERT Certification for Cybersecurity Oversight from Carnegie Mellon’s Software Engineering Institute.